Latest Breaking News On - Vedotin trials - Page 1 : comparemela.com

- Long-term follow-up data for PADCEV® with KEYTRUDA® in advanced bladder cancer to be featured as oral presentation – - Updated Phase 1 data on first-in-class integrin beta-6. | April 26, 2023

United statesDisitamab vedotinEnfortumab vedotinRoger danseySeagen incExchange commissionEuropean unionPresentations of companyAmerican society of clinical oncologyClinical oncologyAnnual meetingChief medical officerVedotin trialsPipeline trialsAnnual reportSeagen inc stock exchange